SAB Biotherapeutics, Inc. (SABSW) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $1.32M | -40.9% |
| 2023 | $2.24M | -90.6% |
| 2022 | $23.90M | -60.7% |
| 2021 | $60.88M | +10.2% |
| 2020 | $55.24M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $1.32M | -40.9% |
| 2023 | $2.24M | -90.6% |
| 2022 | $23.90M | -60.7% |
| 2021 | $60.88M | +10.2% |
| 2020 | $55.24M | — |